These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 31023261)

  • 21. External beam radiotherapy boost versus surgical debulking followed by radiotherapy for the treatment of metastatic lymph nodes in cervical cancer: A systematic review and meta-analysis.
    Bizzarri N; Di Berardino S; Benkortbi K; Balaya V; Gambacorta MA; Macchia G; Boulvain M; Feki A; Mathevet P; Lecuru F; Querleu D; Ferrandina G; Scambia G; Guani B
    Eur J Surg Oncol; 2024 Apr; 50(4):108013. PubMed ID: 38401353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of nodal boost irradiation and MR-based brachytherapy on oncologic outcomes in node-positive cervical cancer.
    Tiwari R; Narayanan GS; Reddy VP; Vishwanathan B; Narayanan S; Venugopal R
    Gynecol Oncol; 2021 Oct; 163(1):110-116. PubMed ID: 34304907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose escalated intensity modulated radiotherapy in the treatment of cervical cancer.
    Cihoric N; Tsikkinis A; Tapia C; Aebersold DM; Zlobec I; Lössl K
    Radiat Oncol; 2015 Nov; 10():240. PubMed ID: 26597282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic Impact of Pretreatment Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography SUVmax in Patients With Locally Advanced Cervical Cancer.
    Cima S; Perrone AM; Castellucci P; Macchia G; Buwenge M; Cammelli S; Cilla S; Ferioli M; Ferrandina G; Galuppi A; Salizzoni E; Rubino D; Fanti S; De Iaco P; Morganti AG
    Int J Gynecol Cancer; 2018 Mar; 28(3):575-580. PubMed ID: 29372911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postoperative external beam irradiation with and without brachytherapy in pelvic node-positive IB1-IIA2 cervical cancer patients: a retrospective clinical study.
    Li L; Kou X; Feng X; Zhang M; Chao H; Wang L
    Radiat Oncol; 2015 Sep; 10():189. PubMed ID: 26377326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor total lesion glycolysis and number of positive pelvic lymph nodes on pretreatment positron emission tomography/computed tomography (PET/CT) predict survival in patients with locally advanced cervical cancer.
    De Cuypere M; Lovinfosse P; Gennigens C; Hermesse J; Rovira R; Duch J; Goffin F; Hustinx R; Kridelka F
    Int J Gynecol Cancer; 2020 Nov; 30(11):1705-1712. PubMed ID: 33033165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical outcomes following conventional external beam radiotherapy boost in Japanese patients with cervical cancer who are ineligible for intracavitary brachytherapy.
    Ito K; Shimizuguchi T; Karasawa K
    Jpn J Clin Oncol; 2019 Mar; 49(3):270-275. PubMed ID: 30576504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inverse Planned High-Dose-Rate Brachytherapy for Locoregionally Advanced Cervical Cancer: 4-Year Outcomes.
    Tinkle CL; Weinberg V; Chen LM; Littell R; Cunha JAM; Sethi RA; Chan JK; Hsu IC
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1093-1100. PubMed ID: 26194683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of 18F-fluorodeoxyglucose uptake in pelvic lymph nodes in patients with cervical cancer treated with definitive chemoradiotherapy.
    Onal C; Guler OC; Reyhan M; Yapar AF
    Gynecol Oncol; 2015 Apr; 137(1):40-6. PubMed ID: 25641567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reviewing the role of parametrial boost in patients with cervical cancer with clinically involved parametria and staged with positron emission tomography.
    Rajasooriyar C; Van Dyk S; Lindawati M; Bernshaw D; Kondalsamy-Chennakesavan S; Narayan K
    Int J Gynecol Cancer; 2012 Nov; 22(9):1532-7. PubMed ID: 23027037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pelvic nodal CTV from L4-L5 or aortic bifurcation? An audit of the patterns of regional failures in cervical cancer patients treated with pelvic radiotherapy.
    Rai B; Bansal A; Patel F; Gulia A; Kapoor R; Sharma SC
    Jpn J Clin Oncol; 2014 Oct; 44(10):941-7. PubMed ID: 25104792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
    Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
    Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pre-treatment surgical para-aortic lymph node assessment in locally advanced cervical cancer.
    Brockbank E; Kokka F; Bryant A; Pomel C; Reynolds K
    Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD008217. PubMed ID: 23543561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pre-treatment surgical para-aortic lymph node assessment in locally advanced cervical cancer.
    Brockbank E; Kokka F; Bryant A; Pomel C; Reynolds K
    Cochrane Database Syst Rev; 2011 Apr; (4):CD008217. PubMed ID: 21491407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nodal failure after chemo-radiation and MRI guided brachytherapy in cervical cancer: Patterns of failure in the EMBRACE study cohort.
    Nomden CN; Pötter R; de Leeuw AAC; Tanderup K; Lindegaard JC; Schmid MP; Fortin I; Haie-Meder C; Mahantshetty U; Hoskin P; Segedin B; Bruheim K; Rai B; Huang F; Cooper R; Van Der Steen Banasik E; Van Limbergen E; Jürgenliemk-Schulz IM;
    Radiother Oncol; 2019 May; 134():185-190. PubMed ID: 31005214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnetic resonance imaging after external beam radiotherapy and concurrent chemotherapy for locally advanced cervical cancer helps to identify patients at risk of recurrence.
    Angeles MA; Baissas P; Leblanc E; Lusque A; Ferron G; Ducassou A; Martínez-Gómez C; Querleu D; Martinez A
    Int J Gynecol Cancer; 2019 Mar; 29(3):480-486. PubMed ID: 30712019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maximum Standardized Uptake Value of Pelvic Lymph Nodes in [18F]-Fluorodeoxyglucose Positron Emission Tomography Is a Prognostic Factor for Para-Aortic Lymph Node Recurrence in Pelvic Node-Positive Cervical Cancer Treated With Definitive Chemoradiotherapy.
    Kim DH; Kim WT; Bae JS; Ki YK; Park D; Suh DS; Kim KH; Lee JH; Lee JY; Jeon HS; Nam JH
    Int J Gynecol Cancer; 2016 Sep; 26(7):1274-80. PubMed ID: 27465890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the Prognostic Value of F-18 Pet Metabolic Parameters of Primary Tumors and Regional Lymph Nodes in Patients with Locally Advanced Cervical Cancer Who Are Treated with Concurrent Chemoradiotherapy.
    Chong GO; Jeong SY; Park SH; Lee YH; Lee SW; Hong DG; Kim JC; Lee YS; Cho YL
    PLoS One; 2015; 10(9):e0137743. PubMed ID: 26368542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of radiation doses to the para-aortic, pelvic, and inguinal lymph nodes delivered by image-guided adaptive brachytherapy in locally advanced cervical cancer.
    Mohamed SM; Aagaard T; Fokdal LU; Pedersen EM; Lindegaard JC; Tanderup K
    Brachytherapy; 2015; 14(1):56-61. PubMed ID: 25176182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Outcome of cervical carcinoma with locoregional lymph node involvement by FDG-PET].
    Paumier A; Blanchard P; Mazeron R; Dumas I; Morice P; Lhomme C; Leboulleux S; Haie-Meder C
    Cancer Radiother; 2012 May; 16(3):183-9. PubMed ID: 22387194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.